Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies
Open Access

Poor Prognosis With Intravesical Bacillus Calmette-Guérin History After Photodynamic Diagnosis-assisted Transurethral Resection Using 5-Aminolevulinic Acid

TOMOYUKI MAKINO, MITSUO OFUDE, TETSUYA KAWAHARA, TOMOHIRO HORI, SATOKO URATA and TOHRU MIYAGI
In Vivo November 2022, 36 (6) 2952-2959; DOI: https://doi.org/10.21873/invivo.13038
TOMOYUKI MAKINO
1Department of Urology, Ishikawa Prefectural Central Hospital, Kanazawa, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mackeeen511{at}gmail.com
MITSUO OFUDE
2Department of Urology, KKR Hokuriku Hospital, Kanazawa, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TETSUYA KAWAHARA
1Department of Urology, Ishikawa Prefectural Central Hospital, Kanazawa, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOMOHIRO HORI
1Department of Urology, Ishikawa Prefectural Central Hospital, Kanazawa, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SATOKO URATA
1Department of Urology, Ishikawa Prefectural Central Hospital, Kanazawa, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOHRU MIYAGI
1Department of Urology, Ishikawa Prefectural Central Hospital, Kanazawa, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 36 no. 6 2952-2959
DOI 
https://doi.org/10.21873/invivo.13038
PMID 
36309406

Published By 
International Institute of Anticancer Research
Print ISSN 
0258-851X
Online ISSN 
1791-7549
History 
  • Received September 15, 2022
  • Revision received September 28, 2022
  • Accepted September 29, 2022
  • Published online October 29, 2022.

Copyright & License 
Copyright © 2022 The Author(s). Published by the International Institute of Anticancer Research. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license (https://creativecommons.org/licenses/by-nc-nd/4.0).

Author Information

  1. TOMOYUKI MAKINO1⇑,
  2. MITSUO OFUDE2,
  3. TETSUYA KAWAHARA1,
  4. TOMOHIRO HORI1,
  5. SATOKO URATA1 and
  6. TOHRU MIYAGI1
  1. 1Department of Urology, Ishikawa Prefectural Central Hospital, Kanazawa, Japan;
  2. 2Department of Urology, KKR Hokuriku Hospital, Kanazawa, Japan
  1. Correspondence to: Tomoyuki Makino, MD, Ph.D., Department of Urology, Ishikawa Prefectural Central Hospital, 2-1 Kuratsukihigashi, Kanazawa 920-8530, Japan. Tel: +81 762378211, Fax: +81 762385366, e-mail: mackeeen511{at}gmail.com
View Full Text

Statistics from Altmetric.com

Cited By...

  • 3 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

In Vivo: 36 (6)
In Vivo
Vol. 36, Issue 6
November-December 2022
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Poor Prognosis With Intravesical Bacillus Calmette-Guérin History After Photodynamic Diagnosis-assisted Transurethral Resection Using 5-Aminolevulinic Acid
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
4 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Poor Prognosis With Intravesical Bacillus Calmette-Guérin History After Photodynamic Diagnosis-assisted Transurethral Resection Using 5-Aminolevulinic Acid
TOMOYUKI MAKINO, MITSUO OFUDE, TETSUYA KAWAHARA, TOMOHIRO HORI, SATOKO URATA, TOHRU MIYAGI
In Vivo Nov 2022, 36 (6) 2952-2959; DOI: 10.21873/invivo.13038

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Poor Prognosis With Intravesical Bacillus Calmette-Guérin History After Photodynamic Diagnosis-assisted Transurethral Resection Using 5-Aminolevulinic Acid
TOMOYUKI MAKINO, MITSUO OFUDE, TETSUYA KAWAHARA, TOMOHIRO HORI, SATOKO URATA, TOHRU MIYAGI
In Vivo Nov 2022, 36 (6) 2952-2959; DOI: 10.21873/invivo.13038
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Radiodynamic Therapy Using 5-Aminolevulinic Acid as a New Treatment Option for Osteosarcoma: An In Vitro and In Vivo Study
  • Comparing Clinical Efficacy of Different Bacillus Calmette-Guerin Strains in Patients With T1 High Grade Bladder Cancer
  • Google Scholar

More in this TOC Section

  • Observational Study on the Effectiveness of L-Arginine Plus Vitamin C in the Management of Cancer-related Fatigue
  • Signal Detection Analysis of Hypnotic-induced Respiratory Depression
  • Development and Validation of an EHR-based Algorithm for Identifying Pneumocystis jirovecii Pneumonia
Show more Clinical Studies

Keywords

  • 5-aminolevulinic acid
  • photodynamic diagnosis
  • fluorescence
  • transurethral resection
  • bladder cancer
  • urothelial carcinoma
  • Bacillus Calmette-Guérin
In Vivo

© 2026 In Vivo

Powered by HighWire